Hope, I told you 1) I am not an investor in AMRN; 2) I gave you the exact PR link and article. I asked you to prove your point with the info, which you did not previously do and neither did you provide the links now. I also explained that this is a huge trial with many arms, and different sub studies so there are multiple different ways to talk about it. There are multiple articles. So it probably is not a good case for discussing precedent on this much smaller and narrower study.
That you think they are not embargoed is shocking to me. That you seem to be suggesting they are lying because if AMRN, I think shows a level of naïveté and incapacity to distinguish different circumstances that maybe you should not invest in biotech.
There are clearly embargoes, they have given you a preview via scientific presentations. If you think they are lying to you, you should absolutely not invest in such a company. I have divested often at a profit, where subsequently a stock has declined, because I distrusted management of a biotech, that is a perfectly honorable thing to do. But spending time here making what appears to me to be a not useful comparison, some of which I saw with my own research was not directly comparable, and suggesting they are lying is really not helpful to you or anyone else.
News 
Market Data 
Discover 
